UBS Group
ONCS

UBS Group’s OncoSec Medical Incorporated ONCS Stock Holding History

UBS Group’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,253
Closed -$13.9K – 11554
2022
Q4 		$13.9K Buy
+8,253
New +$46.2K ﹤0.01% 8127
2022
Q2 		– Sell
-372
Closed -$9K – 11768
2022
Q1 		$9K Buy
+372
New +$7.85K ﹤0.01% 8633
2021
Q3 		– Sell
-117
Closed -$7K – 10824
2021
Q2 		$7K Buy
117
+69
+144% +$6.26K ﹤0.01% 8416
2021
Q1 		$5K Sell
48
-84
-64% -$11.5K ﹤0.01% 8393
2020
Q4 		$19K Sell
132
-114
-46% -$12.2K ﹤0.01% 7006
2020
Q3 		$18K Buy
+246
New +$19.2K ﹤0.01% 6423
2020
Q2 		– Sell
-364
Closed -$10K – 8764
2020
Q1 		$10K Buy
364
+322
+767% +$12K ﹤0.01% 6967
2019
Q4 		$2K Sell
42
-5
-11% -$226 ﹤0.01% 7906
2019
Q3 		$2K Buy
47
+6
+15% +$282 ﹤0.01% 7801
2019
Q2 		$2K Sell
41
-110
-73% -$10.6K ﹤0.01% 7687
2019
Q1 		$19K Buy
151
+53
+54% +$7.24K ﹤0.01% 6376
2018
Q4 		$14K Buy
98
+91
+1,300% +$22.9K ﹤0.01% 7073
2018
Q3 		$2K Sell
7
-44
-86% -$13.5K ﹤0.01% 7795
2018
Q2 		$16K Buy
51
+44
+629% +$15.4K ﹤0.01% 6871
2018
Q1 		$3K Buy
7
+5
+250% +$2.05K ﹤0.01% 7484
2017
Q4 		$1K Hold
2
– – ﹤0.01% 7774
2017
Q3 		$0 Hold
2
– – ﹤0.01% 8189
2017
Q2 		$1K Hold
2
– – ﹤0.01% 7570
2017
Q1 		$1K Sell
2
-20
-91% -$5.82K ﹤0.01% 7517
2016
Q4 		$6K Buy
22
+19
+633% +$6.52K ﹤0.01% 7186
2016
Q3 		$1K Sell
3
-12
-80% -$4.59K ﹤0.01% 7572
2016
Q2 		$6K Sell
15
-2
-12% -$842 ﹤0.01% 7072
2016
Q1 		$9K Buy
17
+15
+750% +$6.4K ﹤0.01% 6743
2015
Q4 		$1K Buy
2
+1
+100% +$752 ﹤0.01% 8216
2015
Q3 		$1K Sell
1
-16
-94% -$21K ﹤0.01% 8275
2015
Q2 		$24K Buy
+17
New +$25.5K ﹤0.01% 6730

Other funds holding ONCS

FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's ONCS Position: Q1 2023 in Review

UBS Group sold out of OncoSec Medical Incorporated (ONCS) in Q1 2023, closing a stake of 8,253 shares — an estimated $13.9K sold.

UBS Group first reported a position in ONCS in Q2 2015 and held it in 26 quarters. The position peaked at $24K in Q2 2015. 12 funds tracked by Wall St. Rank hold ONCS as of Q1 2023.

  • UBS Group reported no remaining OncoSec Medical Incorporated position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 8,253 OncoSec Medical Incorporated shares in Q1 2023, an estimated $13.9K.
  • UBS Group first reported a position in OncoSec Medical Incorporated in Q2 2015 and held it in 26 quarters.
  • UBS Group's OncoSec Medical Incorporated position peaked at $24K in Q2 2015.
  • 12 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.